Michael Petrus

1.1k total citations
24 papers, 751 citations indexed

About

Michael Petrus is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Petrus has authored 24 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 7 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Petrus's work include T-cell and Retrovirus Studies (11 papers), Immune Cell Function and Interaction (10 papers) and Lymphoma Diagnosis and Treatment (6 papers). Michael Petrus is often cited by papers focused on T-cell and Retrovirus Studies (11 papers), Immune Cell Function and Interaction (10 papers) and Lymphoma Diagnosis and Treatment (6 papers). Michael Petrus collaborates with scholars based in United States, Japan and France. Michael Petrus's co-authors include Thomas A. Waldmann, John D. Noti, Richard N. Bamford, Michiyuki Maeda, Bonita R. Bryant, Liyanage P. Perera, Thomas A. Fleisher, Masao Nakagawa, Marshall E. Kadin and Kevin C. Conlon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Molecular and Cellular Biology.

In The Last Decade

Michael Petrus

24 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Petrus United States 16 440 309 190 149 65 24 751
Samuel Y. Ng United States 12 464 1.1× 206 0.7× 571 3.0× 183 1.2× 147 2.3× 19 1.1k
Matthew A. Care United Kingdom 16 251 0.6× 145 0.5× 413 2.2× 183 1.2× 84 1.3× 35 817
Y Takihara Japan 17 635 1.4× 219 0.7× 298 1.6× 138 0.9× 140 2.2× 35 1.1k
Vadim Deyev United States 13 458 1.0× 238 0.8× 152 0.8× 167 1.1× 58 0.9× 17 759
Liang‐Ji Zhou United States 9 781 1.8× 205 0.7× 320 1.7× 131 0.9× 69 1.1× 10 1.1k
Anthony Warford United Kingdom 14 186 0.4× 166 0.5× 276 1.5× 133 0.9× 50 0.8× 25 663
Leah J. Hogdal United States 12 203 0.5× 236 0.8× 412 2.2× 72 0.5× 105 1.6× 20 831
Deborah Webb United States 11 502 1.1× 290 0.9× 253 1.3× 56 0.4× 52 0.8× 15 894
Tomonori Higuchi Japan 13 134 0.3× 205 0.7× 250 1.3× 51 0.3× 64 1.0× 27 560
Takuji Yamauchi Japan 13 288 0.7× 184 0.6× 231 1.2× 130 0.9× 222 3.4× 50 772

Countries citing papers authored by Michael Petrus

Since Specialization
Citations

This map shows the geographic impact of Michael Petrus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Petrus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Petrus more than expected).

Fields of papers citing papers by Michael Petrus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Petrus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Petrus. The network helps show where Michael Petrus may publish in the future.

Co-authorship network of co-authors of Michael Petrus

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Petrus. A scholar is included among the top collaborators of Michael Petrus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Petrus. Michael Petrus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellon, Marcia, Izabela Bialuk, Veronica Galli, et al.. (2021). Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases. Molecular Cancer. 20(1). 86–86. 9 indexed citations
2.
Dubois, Sigrid, Miloš D. Miljković, Thomas A. Fleisher, et al.. (2021). Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies. Journal for ImmunoTherapy of Cancer. 9(4). e002193–e002193. 28 indexed citations
3.
Wei, Wei, Zhihui Song, Wenming Xiao, et al.. (2020). A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models. Clinical Cancer Research. 26(15). 4093–4106. 20 indexed citations
4.
Song, Zhihui, Wei Wei, Wenming Xiao, et al.. (2020). Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma. Proceedings of the National Academy of Sciences. 117(46). 28980–28991. 17 indexed citations
5.
Daenthanasanmak, Anusara, Meili Zhang, Bonita R. Bryant, et al.. (2020). Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia. Translational Oncology. 14(1). 100913–100913. 8 indexed citations
6.
Wang, Hongbo, Wei Wei, Jing‐Ping Zhang, et al.. (2020). A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma. Leukemia. 35(7). 1976–1989. 20 indexed citations
7.
Conlon, Kevin C., E. Lake Potter, Stefania Pittaluga, et al.. (2019). IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion. Clinical Cancer Research. 25(16). 4945–4954. 95 indexed citations
8.
Zhang, Meili, Péter Várnai, Gábor Mocsár, et al.. (2019). IL-2 receptors preassemble and signal in the ER/Golgi causing resistance to antiproliferative anti–IL-2Rα therapies. Proceedings of the National Academy of Sciences. 116(42). 21120–21130. 19 indexed citations
9.
Perera, Liyanage P., Meili Zhang, Masao Nakagawa, et al.. (2017). Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T‐cell malignancies. American Journal of Hematology. 92(9). 892–901. 71 indexed citations
10.
Ju, Lili, Meili Zhang, Kelli M. Wilson, et al.. (2016). Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin’s lymphoma. Proceedings of the National Academy of Sciences. 113(6). 1624–1629. 35 indexed citations
11.
Zhang, Meili, Lesley A. Mathews Griner, Lili Ju, et al.. (2015). Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia. Retrovirology. 12(S1). 5 indexed citations
12.
Zhang, Meili, Lesley A. Mathews Griner, Lili Ju, et al.. (2015). Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2–dependent adult T-cell leukemia. Proceedings of the National Academy of Sciences. 112(40). 12480–12485. 77 indexed citations
13.
Ju, Lili, Meili Zhang, Michael Petrus, et al.. (2014). Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia. Retrovirology. 11(1). 43–43. 15 indexed citations
14.
15.
Waldmann, Thomas A., Kevin C. Conlon, Donn M. Stewart, et al.. (2012). Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood. 121(3). 476–484. 56 indexed citations
16.
Morris, John C., John E. Janik, Jeffrey D. White, et al.. (2005). Preclinical and phase I clinical trial of blockade of IL-15 using Mikβ1 monoclonal antibody in T cell large granular lymphocyte leukemia. Proceedings of the National Academy of Sciences. 103(2). 401–406. 51 indexed citations
17.
Noti, John D., et al.. (1996). Regulation of the leukocyte integrin gene CD11c is mediated by AP1 and Ets transcription factors. Molecular Immunology. 33(2). 115–127. 22 indexed citations
18.
Noti, John D., et al.. (1996). Sp1 Binds Two Sites in the CD11c Promoter In Vivo Specifically in Myeloid Cells and Cooperates with AP1 to Activate Transcription. Molecular and Cellular Biology. 16(6). 2940–2950. 91 indexed citations
19.
Rancé, F., et al.. (1991). [Early neurotoxicity of high-dose of methotrexate and tetrahydrobiopterin deficiency].. PubMed. 48(10). 719–22. 7 indexed citations
20.
Cano, Jean Paul, et al.. (1988). [Intrarectal clonazepam in children. Plasma and CSF levels].. PubMed. 43(7). 603–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Y. Ng Breakdown of academic impact, for papers by Matthew A. Care Breakdown of academic impact, for papers by Y Takihara Breakdown of academic impact, for papers by Vadim Deyev Breakdown of academic impact, for papers by Liang‐Ji Zhou Breakdown of academic impact, for papers by Anthony Warford Breakdown of academic impact, for papers by Leah J. Hogdal Breakdown of academic impact, for papers by Deborah Webb Breakdown of academic impact, for papers by Tomonori Higuchi Breakdown of academic impact, for papers by Takuji Yamauchi
Rankless by CCL
2026